Company intelligence / Profile preview

Aclid

Unknown, Unknown, United Statesaclid.bio ↗

Ownership: Private
Development stage: Commercial

Overview

Aclid provides an automated, real-time screening and customer verification platform to ensure biosecurity, export control compliance, and environmental health & safety for DNA/RNA order processing. The system delivers rapid threat assessments, risk profiles, license verification, biosafety checks, and manages regulatory compliance at checkout. It is used by leading biotech manufacturers and governments to prevent misuse of synthetic biology tools[1][2][3][4].

Therapeutic areas: Other
Modalities: Not directly therapeutic; focuses on compliance and security for gene synthesis (DNA/RNA)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Leading biotech manufacturersGovernments using the platform for biosecurity[1]

Beyond the preview

Go deeper on Aclid.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aclid.

Explore the full profile